LISI 2016 ANNUAL REPORT
I
7
“The acquisition of the American
company REMMELE Medical Operations
is one of the major events of 2016.
It propels LISI MEDICAL into the world’s
Top 5 manufacturers of prostheses
and medical instruments”
Workforce registered
Staff
11,587
Equity capital
in €M
865
€M
Capital expenditures
in €M and in % of sales
119.6
€M
7.6
%
of sales
793
2015
709
2014
626
2013
111.6
2015
7,6%
90.6
2014
6,9%
87.7
2013
7,6%
10,923
2015
10,701
2014
9,239
2013